Organs-on-chips Market Size

Organs-on-chips Market Size

Organs-on-chips Market was valued at USD 116.5 million in 2023 and is estimated to witness 32.2% CAGR from 2024 to 2032. The market has witnessed significant growth and innovation in recent years, driven by the increasing demand for more accurate and reliable in-vitro models of human organs for drug discovery, toxicity testing, and disease modelling.

To get key market trends

  Download Free Sample

These microfluidic devices hold the potential to revolutionize the pharmaceutical and healthcare industries by offering the more physiologically relevant research and development (R&D) platforms. Additionally, organs-on-a-chip technology offers a significant benefit by potentially minimizing the need for animals in medical research, aligning with ethical practices.

For instance, the Humane Society International, reported that over 115 million animals are used for clinical testing worldwide, a number that could substantially decrease with organ-on-chip technology. The organ-on-chip system's capability to replicate human organs affordably positions it as a highly promising tool as a non-animal alternative testing for drug discovery contributing to compelling market growth.

Organ-on-chip refers to a microfluidic system that replicates the physiological and functional characteristics of human organs on a microscale platform. The bioengineered chips mimic the complexities of organs, supporting the accurate representation of drug responses, disease mechanisms, and tissue interactions with unprecedented accuracy. Organ-on-chip systems integrate living cells and microfluidic channels, creating a realistic in-vitro environment for advanced research and development applications.